SEC v. JianQing Li

JianQing Li, a former investment analyst, allegedly insider traded in the securities of at least twelve healthcare companies from February 2024 through October 2025. According to the SEC’s complaint, Li had access to confidential information about his employer’s healthcare company clients’ upcoming securities offerings and clinical drug data, which his employer had agreed to keep secret. Li allegedly misappropriated that confidential information and, before the information became public, traded in the healthcare companies’ securities for his own personal benefit, realizing more than $320,000 in illicit profits.

Summary generated from official Securities and Exchange Commission press release